Production (Stage)
CARGO Therapeutics, Inc.
CRGX
$4.42
$0.0451.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -85.98% | -8.42% | 5.50% | -23.84% | -11.64% |
| Total Depreciation and Amortization | -10.49% | -23.60% | -13.94% | 11.81% | 68.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 150.36% | 21.08% | 53.92% | 73.62% | -26.28% |
| Change in Net Operating Assets | 777.32% | 187.64% | -197.97% | 101.15% | 702.89% |
| Cash from Operations | -8.04% | 11.96% | -12.94% | -16.38% | -4.02% |
| Capital Expenditure | 39.37% | 40.85% | 27.20% | -13.50% | 50.75% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.58% | 168.25% | -905.88% | 101.80% | -81,879.55% |
| Cash from Investing | 23.96% | 165.46% | -1,239.09% | 101.29% | -9,784.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -87.74% | -22.89% | -99.61% | 397,396.15% | -99.99% |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 97.78% |
| Cash from Financing | 121.35% | -144.28% | -99.61% | 99,474.04% | -100.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61.55% | 91.75% | -214.36% | 122.23% | -193.71% |